Building on studies examining the roles of microRNAs in cancer cell-derived circulating microvesicles, a team of researcher from Ohio State University this month reported on the discovery that two such miRNAs trigger a pro-metastatic inflammatory response by binding to toll-like
Gen-Probe has been awarded US Patent No. 8,192,992, "System and method for incubating the contents of a reaction receptacle."
Kelly Ammann, Robert Schneider, and Robert Smith are named as inventors on the patent.
Researchers at OSU used the 75-teraflop supercomputer to perform sequence alignments and statistical analysis as well as to generate phylogenetic trees to shed light on the evolutionary history of the PARP protein family.